All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Dova Pharmaceuticals Inc., of Durham, N.C., said the NDA for avatrombopag has been accepted for filing and has been granted priority review by the FDA with a PDUFA date of May 21, 2018.
